Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine
暂无分享,去创建一个
C. Mcevoy | A. Falsey | S. Little | M. Pangalos | M. Hassman | S. Buchbinder | M. Mulligan | M. Robb | E. Daar | L. Corey | K. Neuzil | L. Bush | Antonio Gonzalez-Lopez | N. Mueller | H. Janes | D. Benkeser | A. Durbin | I. Hirsch | M. Sobieszczyk | E. Dejesus | B. Kirkpatrick | M. Nason | Sergio L Vargas | M. Keefer | B. Pahud | Justin A. Green | K. Shoemaker | Therese Takas | T. Villafana | T. Tong | J. Cowden | J. Pullman | R. Call | E. Kelly | Jill Maaske | Richard P. Marshall | Alfredo Guerreros Benavides | P. Pickrell | Joel Solis | Stephanie Sproule | Margaret Brewinski Isaacs | Temitope Oyedele | William Hahn | Julie Hunt | Quito Osuna Carr | William W. Hahn | J. Green | Michael Hassman | Kathryn Shoemaker
[1] L. Danon,et al. Effectiveness of BNT162b2 and ChAdOx1 nCoV-19 COVID-19 vaccination at preventing hospitalisations in people aged at least 80 years: a test-negative, case-control study , 2021, Lancet. Infectious Diseases (Print).
[2] C. Robertson,et al. Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study , 2021, BMJ.
[3] Colin Simpson,et al. Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study , 2021, The Lancet.
[4] J. Bussel,et al. SARS-CoV-2 Vaccine–Induced Immune Thrombotic Thrombocytopenia , 2021, The New England journal of medicine.
[5] D. Goldblatt,et al. Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination , 2021, The New England journal of medicine.
[6] S. Koepsell,et al. Thrombotic Thrombocytopenia after Ad26.COV2.S Vaccination , 2021, The New England journal of medicine.
[7] F. Krammer. Correlates of protection from SARS-CoV-2 infection , 2021, The Lancet.
[8] Andreas Greinacher,et al. Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination , 2021, The New England journal of medicine.
[9] Fridtjof Lund-Johansen,et al. Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination , 2021, The New England journal of medicine.
[10] D. Bonsall,et al. Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial , 2021, The Lancet.
[11] S. Madhi,et al. Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant , 2021, The New England Journal of Medicine.
[12] K. Neuzil,et al. Are some COVID vaccines better than others? Interpreting and comparing estimates of efficacy in trials of COVID-19 vaccines , 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[13] Eun-Ju Lee,et al. Thrombocytopenia following Pfizer and Moderna SARS‐CoV‐2 vaccination , 2021, American journal of hematology.
[14] Nguyen H. Tran,et al. Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials , 2021, The Lancet.
[15] Nguyen H. Tran,et al. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK , 2020, Lancet.
[16] Nguyen H. Tran,et al. Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial. , 2020, Lancet.
[17] Lindsay N. Carpp,et al. Clinical Endpoints for Evaluating Efficacy in COVID-19 Vaccine Trials , 2020, Annals of Internal Medicine.
[18] John R. Mascola,et al. A strategic approach to COVID-19 vaccine R&D , 2020, Science.
[19] Arman Behnam,et al. COVID-19 Cases , 2020 .
[20] Medicines And Healthcare Products Regulatory Agency , 2020, Definitions.
[21] Ministerio de Salud Pública República Dominicana. The Coronavirus , 2020 .
[22] G. Zou,et al. A modified poisson regression approach to prospective studies with binary data. , 2004, American journal of epidemiology.